2-(4-fluorophenyl)-5-methoxy-6-[3-(methoxymethyl)-5-methyl-1,2-oxazol-4-yl]-1-benzofuran-3-carboxylic acid
C22H18FNO6 — CID 142773413
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-fluorophenyl)-5-methoxy-6-[3-(methoxymethyl)-5-methyl-1,2-oxazol-4-yl]-1-benzofuran-3-carboxylic acid
2-(4-fluorophenyl)-5-methoxy-6-[3-(methoxymethyl)-5-methyl-1,2-oxazol-4-yl]-1-benzofuran-3-carboxylic acid (PubChem CID 142773413) has the molecular formula C22H18FNO6 and a molecular weight of 411.39 g/mol. Its IUPAC name is 2-(4-fluorophenyl)-5-methoxy-6-[3-(methoxymethyl)-5-methyl-1,2-oxazol-4-yl]-1-benzofuran-3-carboxylic acid.
Molecular Properties
| Compound Name | 2-(4-fluorophenyl)-5-methoxy-6-[3-(methoxymethyl)-5-methyl-1,2-oxazol-4-yl]-1-benzofuran-3-carboxylic acid |
|---|---|
| PubChem CID | 142773413 |
| Molecular Formula | C22H18FNO6 |
| Molecular Weight | 411.39 g/mol |
| Exact Mass | 411.11 |
| IUPAC Name | 2-(4-fluorophenyl)-5-methoxy-6-[3-(methoxymethyl)-5-methyl-1,2-oxazol-4-yl]-1-benzofuran-3-carboxylic acid |
| SMILES | COCc1noc(C)c1-c1cc2oc(-c3ccc(F)cc3)c(C(=O)O)c2cc1OC |
| InChI | InChI=1S/C22H18FNO6/c1-11-19(16(10-27-2)24-30-11)14-9-18-15(8-17(14)28-3)20(22(25)26)21(29-18)12-4-6-13(23)7-5-12/h4-9H,10H2,1-3H3,(H,25,26) |
| InChIKey | VZGBIALQXAIWJX-UHFFFAOYSA-N |
| XLogP | 5.06 |
| TPSA | 94.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 411.39 |
| LogP ≤ 5 | 5.06 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142773413 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.